Summary
- Current Price
- As of today, AIDX price is $0.53, down -4.29% in the most recent trading session on
- Current Price All-Time High
- AIDX price is currently -98.94% below its historical high of $50.00 set on
- Market Cap
- AIDX current market cap is $7M
- Revenue
- AIDX current annual revenue is $2.05M, up +16.71% year-over-year
- Next Earnings
- The next earnings release for AIDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | 20/20 Biolabs, Inc. |
| Ticker | NASDAQ: AIDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 2020biolabs.com |
| Employees | 13 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.53 | ||
| Price, 1D Change | -4.29% | |
| $7M | ||
| - | ||
| - | ||
| 0.30 | ||
| $2.05M | ||
| Revenue, 1Y Change | +16.71% | |
| -$0.36 | ||
| EPS, 1Y Change | +69.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.36 | ||
| EPS Estimate | -$0.42 | N/A |
| EPS Est. Change | -17.32% | N/A |
| $2.05M | ||
| Revenue Estimate | $2.95M | N/A |
| Revenue Est. Change | +44.20% | N/A |
| $0.53 | ||
| Price Target | $5.00 | - |
| Price Tgt. Change | +842.51% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.16 | - | |
| - | -$0.36 | - | |
| -$0.42 | N/A | -17.32% | |
| -$0.38 | N/A | -6.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.75M | - | |
| - | $2.05M | - | |
| $2.95M | N/A | +44.20% | |
| $5.77M | N/A | +182.24% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +16.71% | ||
| -81.51% | ||
| +69.14% | ||
| -255.65% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.53 | ||
| $1.71 | ||
| $0.55 | ||
| - | ||
| $0.69 | ||
| -$0.01 | ||
| 0.30 | ||
| $0.06 | ||
| 54.63 | ||
| 91.63% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.05M | ||
| -$0.36 | ||
| $604.50K | ||
| 29.56% | ||
| -$3.33M | ||
| -162.87% | ||
| -$3.74M | ||
| -182.82% | ||
| -$3.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -70.76 | ||
| 0.60 | ||
| 0.55 | ||
| - | ||
| - | ||
| -12.72 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.32 | ||
| 4.18 | ||
| -0.65 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$66.40K | ||
| $1.03M | ||
| $4.14M | ||
| $1.47M | ||
| $4.16M | ||
| $2.46M | ||
| $1.36M | ||
| $250.60K | ||
| $868.50K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $5.78M | ||
| $3.94M | ||
| $1.44M | ||
| $0.00 | ||
| $78.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$1.92M | ||
| $0.00 | ||
| $1.16M | ||
| $0.00 | ||
| -$1.92M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Maxim Group |
Analyst sentiment
Institutional ownership
Screeners with AIDX
FAQ
- What is the ticker symbol for 20/20 Biolabs, Inc.?
- The ticker symbol for 20/20 Biolabs, Inc. is NASDAQ:AIDX
- Does 20/20 Biolabs, Inc. pay dividends?
- No, 20/20 Biolabs, Inc. does not pay dividends
- What sector is 20/20 Biolabs, Inc. in?
- 20/20 Biolabs, Inc. is in the Healthcare sector
- What industry is 20/20 Biolabs, Inc. in?
- 20/20 Biolabs, Inc. is in the Medical Devices industry
- What country is 20/20 Biolabs, Inc. based in?
- 20/20 Biolabs, Inc. is headquartered in United States
- When did 20/20 Biolabs, Inc. go public?
- 20/20 Biolabs, Inc. initial public offering (IPO) was on February 19, 2026
- Is 20/20 Biolabs, Inc. in the S&P 500?
- No, 20/20 Biolabs, Inc. is not included in the S&P 500 index
- Is 20/20 Biolabs, Inc. in the NASDAQ 100?
- No, 20/20 Biolabs, Inc. is not included in the NASDAQ 100 index
- Is 20/20 Biolabs, Inc. in the Dow Jones?
- No, 20/20 Biolabs, Inc. is not included in the Dow Jones index
- When was 20/20 Biolabs, Inc. last earnings report?
- 20/20 Biolabs, Inc.'s most recent earnings report was on May 20, 2026
- When does 20/20 Biolabs, Inc. report earnings?
- The next expected earnings date for 20/20 Biolabs, Inc. is August 31, 2026
Data Sources & References
- AIDX Official Website 2020biolabs.com
- AIDX Profile on Yahoo Finance finance.yahoo.com/quote/AIDX
- AIDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aidx